DHAP regimen: Difference between revisions
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} ==Overview== {{PAGENAME}} refers to a chemotherapy regimen consisting of dexamethasone, high-dose cytarabine|cytarabine..." |
No edit summary |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a chemotherapy regimen consisting of [[dexamethasone]], high-dose [[cytarabine|cytarabine (Ara-C)]] and [[cisplatin]], used to treat relapsed and refractory [[non-Hodgkin's|non-Hodgkin's | {{PAGENAME}} refers to a chemotherapy regimen consisting of [[dexamethasone]], high-dose [[cytarabine|cytarabine (Ara-C)]] and [[cisplatin]], used to treat relapsed and refractory [[non-Hodgkin's lymphoma|non-Hodgkin's]] and [[Hodgkin's lymphoma]]. | ||
Line 13: | Line 13: | ||
High dose | High dose | ||
{{chemo|A|Cytarabine (Ara-C)}} | {{chemo|A|Cytarabine (Ara-C)}} | ||
{{chemo|P|Cisplatin}} | {{chemo|P|Cisplatin}} | ||
==Indications== | ==Indications== | ||
Revision as of 18:06, 12 March 2015
WikiDoc Resources for DHAP regimen |
Articles |
---|
Most recent articles on DHAP regimen Most cited articles on DHAP regimen |
Media |
Powerpoint slides on DHAP regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on DHAP regimen at Clinical Trials.gov Clinical Trials on DHAP regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on DHAP regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on DHAP regimen Discussion groups on DHAP regimen Patient Handouts on DHAP regimen Directions to Hospitals Treating DHAP regimen Risk calculators and risk factors for DHAP regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for DHAP regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:
Overview
DHAP regimen refers to a chemotherapy regimen consisting of dexamethasone, high-dose cytarabine (Ara-C) and cisplatin, used to treat relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
Regimen
DDexamethasone
High dose
ACytarabine (Ara-C)
PCisplatin